Processa Pharmaceuticals, Inc., announced that it has enrolled its first patient in the Phase IIA clinical trial of PCS12852 in patients with moderate to severe gastroparesis.
[Processa Pharmaceuticals, Inc.]
Sorry, but the selected Zotpress account can't be found.